• PA
    PA School SurvivalDidactic Year
Subjects
  • 📖Medical Terminology
  • 🦴Gross Anatomy
    • Study Playbook
    • By Region
    • PNS Chart
    • My Lectures
    • Practice
  • 🧬Immunology & Genetics
    • Study Playbook
    • By Topic
    • My Lectures
    • Practice
  • 🧪Physiology
    • Study Playbook
    • By System
    • My Lectures
    • Practice
My material
  • 🗂️My Library
  • ✍️Notes & Sketches
Study Tools
  • 🎓Flashcards
  • 📡To revisit
  • 🗓️Calendar
  • 📈Progress
  • ✅Prep Rounds
  • 🧬Body Systems
  • 💊Pharmacology
  • 🔗Offsite Resources
  • 🧭Guide & FAQ
  • 💡
    Suggest a FeatureLet us know what we can do better — we genuinely want to help you in class.
PANCE Body Systems
  • 🫀Cardiovascular
    11%
  • 🫁Pulmonary
    9%
  • 🍎Gastrointestinal/Nutrition
    8%
  • 💪Musculoskeletal
    8%
  • 🧠Neurology
    7%
  • 🦠Infectious Disease
    7%
  • 💭Psychiatry/Behavioral
    7%
  • 🤰Reproductive
    7%
  • 🦋Endocrine
    6%
  • 👁️Eyes/Ears/Nose/Throat
    6%
  • 🩸Hematology
    5%
  • 🫘Renal
    5%
  • 💧Genitourinary
    4%
  • 🖐️Dermatology
    4%
Weights are study aids — verify each exam cycle.
⌘K
NotesPricingSign in
About·Tools·Terminology·Anatomy playbook·Anatomy by region·Immunology & genetics·Immunology playbook·Physiology·Physiology playbook·Privacy Policy·Terms of Service·PANCE Blueprint

PANCE® is a registered trademark of the National Commission on Certification of Physician Assistants (NCCPA). This application is an independent study resource and is not affiliated with, sponsored by, or endorsed by the NCCPA.

For educational use only. Content is AI-generated, may contain errors, and is not medical advice — always verify against current primary sources and faculty guidance before clinical use.

HomeCardiovascularHypertension (Essential)
🫀

Hypertension (Essential)

Cardiovascular · ~11% of blueprint
🔬Pathophysiology
Multifactorial ↑ systemic vascular resistance &/or cardiac output; most cases primary (essential). Sustained ↑afterload → LVH, vascular remodeling, end-organ damage.
🩺Signs & Symptoms
Usually asymptomatic ('silent killer'), found on screening. End-organ clues: retinopathy, LVH, proteinuria. Severe: headache, visual changes.
🎯Gold Standard Diagnosis
≥2 elevated readings on ≥2 separate visits. AHA/ACC 2025: Stage 1 130–139/80–89, Stage 2 ≥140/90. Confirm with home/ambulatory BP.
💊First-line Treatment
Lifestyle + a first-line class: thiazide-type diuretic, ACEi, ARB, or long-acting dihydropyridine CCB. ACEi/ARB as part of treatment in CKD with moderate–severe albuminuria. Start 2 classes (single-pill combination) in stage 2.
Drug cardsHydrochlorothiazideLisinoprilLosartanAmlodipine
High-Yield Pearl

Suspect secondary HTN if young, resistant, or abrupt: renal artery stenosis, hyperaldosteronism, pheochromocytoma, OSA.

Sources

Reviewed September 2026
  1. 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults — AHA/ACC, 2025
  2. Implementing the 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults — American Heart Association — Hypertension, 2025
  3. Case-Based Applications of the 2025 AHA/ACC/Multispecialty High Blood Pressure Guideline — American Heart Association — Hypertension, 2025
  4. StatPearls: Essential Hypertension — NCBI Bookshelf / StatPearls, 2025

Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.

More Cardiovascular conditions

  • Acute Coronary Syndrome (STEMI)
  • Acute Pericarditis
  • Aortic Dissection
  • Aortic Stenosis
  • Atrial Fibrillation
  • Deep Vein Thrombosis
  • Heart Failure (HFrEF)
  • Hyperlipidemia
  • Hypertrophic Cardiomyopathy
  • Infective Endocarditis
  • Mitral Regurgitation
  • Peripheral Arterial Disease
All Cardiovascular